“A small amount of charity to the needy adds to your very prosperity. Do it – sweetly, smilingly in your own small, modest way”
Those who run into bad portfolio in past for one reason or another can have it reviewed or restructured on

A. Calling at Mob: 08813013300
B. Writing at Email: tilak22b@gmail.com

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!


Dear Friends,

The valuations of Ajanta Pharma, a pharma major is increasing. Its reserves on annualized basis are constantly on the rise and so is the case with sales and net profit/margins on quarterly basis. At the current EPS, it is somewhat over priced and should be bought for med term ; especially with SIP Mode.

It is suffering from higher price to earning at 34 when compared with industry PE of around 31. Otherwise, almost with debt free status, a good dividend pay master with CRR and DPR ratio o 85 : 15, it is a clear buy on each dip. Even its profit generating efficiency level is 36% as on Mar 15.

Kindly buy on each dip for decent return provided it is held with conviction.

Sign In or Register to comment.